Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

OBJECTIVE: The investigation regarding the clinical significance of quantitative hepatitis B core antibody (anti-HBc) during chronic hepatitis B (CHB) treatment is limited. The aim of this study was to determine the performance of anti-HBc as a predictor for hepatitis B e antigen (HBeAg) seroconvers...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Rong, Sun, Jian, Yuan, Quan, Xie, Qing, Bai, Xuefan, Ning, Qin, Cheng, Jun, Yu, Yanyan, Niu, Junqi, Shi, Guangfeng, Wang, Hao, Tan, Deming, Wan, Mobin, Chen, Shijun, Xu, Min, Chen, Xinyue, Tang, Hong, Sheng, Jifang, Lu, Fengmin, Jia, Jidong, Zhuang, Hui, Xia, Ningshao, Hou, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752655/
https://www.ncbi.nlm.nih.gov/pubmed/25586058
http://dx.doi.org/10.1136/gutjnl-2014-308546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752655/
https://www.ncbi.nlm.nih.gov/pubmed/25586058
http://dx.doi.org/10.1136/gutjnl-2014-308546

Ejemplares similares